Women Will Soon Have Access to a More Cost-Effective, Environmentally Friendly Alternative to Sanitary Napkins and Tampons
SAN DIEGO, Nov. 28, 2012 /PRNewswire/ — BIOCOM, the world’s largest regional life sciences association, announces The FemmyCycle®, a novel product from member FemCap, Inc. The FemmyCycle® was granted clearance by The U.S. Food and Drug Administration on November 16, 2012. An eco-friendly alternative to sanitary napkins and tampons, The FemmyCycle® enhances the quality of women’s lives by helping them better manage their menstrual periods.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/women-will-soon-have-access-to-a-more-cost-effective-environmentally-friendly-alternative-to-sanitary-napkins-and-tampons-180475641.html
FemmyCycle® creator Dr. Alfred Shihata is familiar with developing innovative feminine products. His FDA-approved FemCap® is one of the few hormone-free, woman-controlled contraceptive methods available.
“When I developed The FemCap®, my goal was to provide women with a safe, effective, hormone-free birth control device. The motivation behind The FemmyCycle® was much the same–to provide a safer, more convenient alternative to pads and tampons at a lower economic and environmental cost,” Dr. Shihata said.
The FemmyCycle’s® unique, non-spill-design safely collects and holds menstrual flow for up to 12 hours. Collecting menstrual flow rather than absorbing it eliminates the risk of toxic shock syndrome associated with tampons. Additionally, women using the device reported an absence of odor and leaks as the device keeps menstrual fluid away from vaginal walls and vulva and unexposed to air.
The FemmyCycle® can be worn during exercise and other daily activities, so it is ideal for athletes and working women. It is a reusable device made of soft, medical grade silicone and lasts for a year or more, making it an environmentally friendly alternative to tampons and pads. The FemmyCycle® is cost-effective at $39.95 per twin pack and will be available online and in stores in early 2013.
BIOCOM represents more than 550 life science companies in Southern California. The association focuses on initiatives that positively influence the region’s life science community in the development and delivery of innovative products that improve health and quality of life. www.biocom.org
FemCap, Inc. is a Del Mar, California-based company founded by Dr. Alfred Shihata, developer of the FDA-approved FemCap® contraceptive device and The FemmyCycle® menstrual collection cup. www.femcap.com
SOURCE FemCap, Inc.